Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yasemin Ataman-Önal"'
Autor:
Vasco Liberal, Remi Forrat, Cong Zhang, Charles Pan, Matthew Bonaparte, Wushan Yin, Lingyi Zheng, Valeria Viscardi, Yukun Wu, Yasemin Ataman-Önal, Stephen Savarino, Catherine Chen
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT The World Health Organization has recommended prevaccination screening for prior dengue infection as the preferred approach prior to vaccination with the dengue vaccine CYD-TDV. These screening tests need to be highly specific and sensitive,
Externí odkaz:
https://doaj.org/article/28f48a43ca4e49449d8cd2a5d0e56b0d
Autor:
Stephen J, Savarino, Matthew, Bonaparte, Hao, Wang, Gustavo H, Dayan, Remi, Forrat, Ming, Zhu, Shekema, Hodge, Yasemin, Ataman-Önal, Carlos A, DiazGranados
Publikováno v:
The Lancet Microbe. 3:e427-e434
A dengue pre-vaccination test that is convenient, highly specific, and highly sensitive is still needed. The OnSite Dengue IgG rapid diagnostic test (RDT) is a new rapid diagnostic test specifically designed for pre-vaccination screening. We aimed to
Autor:
Matthew Bonaparte, Gustavo H. Dayan, Wang Hao, Carlos A. DiazGranados, Shekema Hodge, Yaniv Lustig, Eli Schwartz, Yasemin Ataman-Önal, Ming Zhu, Stephen Savarino, Remi Forrat
Publikováno v:
The Lancet. Infectious diseases. 21(4)
Summary Background The tetravalent dengue vaccine (CYD-TDV) has been shown to provide protection against dengue disease over 5-year follow-up in participants with previous dengue infection, but increased the risk of dengue hospitalisation and severe
Autor:
Laurent Fraisse, Marie-Helene Grillet, Yasemin Ataman-Önal, Tobias Manigold, Emmanuel Feroldi, Sébastien Laurent, David J. M. Lewis, Patrick Syntin, Benjamin Chousterman, Nicholas Jackson, Michel Doubovetzky, Nicolas Burdin, Ernesto Luna, Daniel Kramer, Nathalie Garçon
Publikováno v:
Vaccine. 38(51)
Vaccines prevent infectious diseases, but vaccination is not without risk and adverse events are reported although they are more commonly reported for biologicals than for vaccines. Vaccines and biologicals must undergo vigorous assessment before and
Autor:
Bruno Guy, Eli Schwartz, Yasemin Ataman-Önal, Carlos A. DiazGranados, Stephen Savarino, Matthew Bonaparte, Sanjay Garg, Yaniv Lustig, Lingyi Zheng
Publikováno v:
Journal of travel medicine. 26(8)
Background In September 2018, the World Health Organization recommended that prevaccination screening be used with the tetravalent dengue vaccine (CYD-TDV), to ensure that only individuals with evidence of prior dengue infection (PDI) are vaccinated.
Autor:
Yaniv Lustig, Lingyi Zheng, Matthew Bonaparte, Carlos A. DiazGranados, Shekema Hodge, James Huleatt, Stephen Savarino, Yasemin Ataman-Önal
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 96:114918
We assessed a dengue IgG rapid diagnostic test (RDT) and IgG enzyme-linked immunosorbent assay (ELISA) to determine their suitability for dengue prevaccination screening. Each exhibited ≥99% specificity. The RDT demonstrated no Zika cross-reactivit
Autor:
Céline Hamelin, Geneviève Choquet-Kastylevsky, Sylvie Pons, Corinne Beaulieu, Yasemin Ataman-Önal, Emilie Cornut, Hader Haidous, Florence Poirier, Eddy Cotte, Claude Lambert, Françoise Piard, Jean-Philippe Charrier
Publikováno v:
The Febs Journal
Colorectal cancer (CRC) is a major public health issue worldwide, and novel tumor markers may contribute to its efficient management by helping in early detection, prognosis or surveillance of disease. The aim of our study was to identify new serum b
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 32:293-305
Poly( d , l -lactic acid) (PLA)-based particles, obtained by the emulsification–diffusion process, were surface-modified by electrostatic adsorption of poly(ethylenimine) (PEI). The amount of immobilized PEI and the conformation of the polycation a
Autor:
Emmanuelle Gorius-Gallet, Michèle Guillotte, Céline Hamelin-Peyron, Yasemin Ataman-Önal, Slobodan Poznanovic, Gerhard P. Schwall, Geneviève Choquet-Kastylevsky, Hader Haidous, Alain Ruffion, Audrey Larue, Sandrine Michel, Virginie Vlaeminck-Guillem
Publikováno v:
Clinical Biochemistry
Clinical Biochemistry, Elsevier, 2014, 47 (10-11), pp.901-908. ⟨10.1016/j.clinbiochem.2014.05.063⟩
Clinical Biochemistry, 2014, 47 (10-11), pp.901-908. ⟨10.1016/j.clinbiochem.2014.05.063⟩
Clinical Biochemistry, Elsevier, 2014, 47 (10-11), pp.901-908. ⟨10.1016/j.clinbiochem.2014.05.063⟩
Clinical Biochemistry, 2014, 47 (10-11), pp.901-908. ⟨10.1016/j.clinbiochem.2014.05.063⟩
International audience; Objectives: Annexin A3 (ANXA3) is a potential marker for prostate cancer (PCa). We aimed to develop robust immunoassays suitable for quantifying ANXA3 in urine samples obtained following digital rectal examination (DRE) in ord
Autor:
N. Xanthopoulos, Vincent Laporte, Thierry Delair, Emmanuelle Laurenceau, Yasemin Ataman-Önal, Zhugen Yang, Eliane Souteyrand, Yann Chevolot, Thomas Gehin, Vincent Dugas, Geneviève Choquet-Kastylevsky
Publikováno v:
Langmuir
Langmuir, American Chemical Society, 2013, 29 (5), pp.1498-1509. ⟨10.1021/la3041055⟩
Langmuir, American Chemical Society, 2013, 29 (5), pp.1498-1509. ⟨10.1021/la3041055⟩
International audience; Antibody microarrays are powerful and high-throughput tools for screening and identifying tumor markers from small sample volumes of only a few microliters. Optimization of surface chemistry and spotting conditions are crucial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcadbbe0f37ce9c43bdfea955227b2d9
https://hal.archives-ouvertes.fr/hal-00872600
https://hal.archives-ouvertes.fr/hal-00872600